Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01998100 · ClinicalTrials.gov registry record · Phase 3
Maximizing Treatment Outcome in Post-Traumatic Stress Disorder (PTSD)
A Phase 3 study of Post Traumatic Stress Disorder, sponsored by University of Texas at Austin.
- Completed
- Registry status
- Phase 3
- Development phase
- 28
- Enrollment target
- 2
- Study locations
NCT01998100 is a Phase 3 study of Post Traumatic Stress Disorder that has completed, run by University of Texas at Austin. The registered enrollment target is 28 participants, below the 1,117-participant average among 144 other Post Traumatic Stress Disorder trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT01998100, a Phase 3 study of Post Traumatic Stress Disorder, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 28 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to examine the efficacy of exercise + therapy to therapy alone to determine if they can improve the effects of prolonged exposure therapy (PE) in reducing symptoms of anxiety associated with Post-traumatic Stress Disorder (PTSD). In addition the two strategies (i.e., exercise + therapy and therapy alone condition) will be compared in terms of levels of brain-derived neurotrophic factor (BDNF). BDNF is a protein that helps to support the survival of existing neurons and stimulate the growth of new neurons and synapses. BDNF is important to learning and memory in general and therefore may be associated with the learning and memory as it relates to PE and corresponding symptoms PTSD improvement.
Conditions Studied
Interventions
- BEHAVIORAL Exercise
- BEHAVIORAL Prolonged Exposure
Study Locations (2)
Texas
- The University of Texas at Austin - Austin
- Southern Methodist University - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2010-09 |
| Est. Completion | 2013-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01998100
The ClinicalTrials.gov registry entry for NCT01998100 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,117-participant average among 144 other Post Traumatic Stress Disorder trials with a reported enrollment target (97% lower). The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which Exercise is the first listed.
NCT01998100 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01998100 about?
NCT01998100 is a clinical study titled "Maximizing Treatment Outcome in Post-Traumatic Stress Disorder (PTSD)". The purpose of this study is to examine the efficacy of exercise + therapy to therapy alone to determine if they can improve the effects of prolonged exposure therapy (PE) in reducing symptoms of anxiety associated with Post-traumatic Stress Disorder (PTSD). In addition the two strategies (i.e., exe...
What is the current status of trial NCT01998100?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 28 participants. The study started on 2010-09. Estimated completion is 2013-07.
What conditions does trial NCT01998100 study?
This clinical trial studies the following conditions: Post Traumatic Stress Disorder.
What interventions are being tested in trial NCT01998100?
The interventions under investigation include: Exercise (BEHAVIORAL), Prolonged Exposure (BEHAVIORAL).
Who is sponsoring clinical trial NCT01998100?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01998100 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
RECRUITING · Phase 3
-
Goal-Directed Sedation in Mechanically Ventilated Infants and Children
RECRUITING · Phase 3
-
MDMA-assisted Massed Prolonged Exposure for PTSD
RECRUITING · Phase 3
-
Frontline Clinician Psilocybin Study
COMPLETED · Phase 3
-
Maximizing Treatment Outcome and Examining Sleep in Post-traumatic Stress Disorder (PTSD)
COMPLETED · Phase 3
-
Comparison of Videoconference and Face-to-Face Delivery of Cognitive Processing Therapy for Posttraumatic Stress Disorder
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.